Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $103.8834 (-4.52%) ($103.7302 - $109.1695) on Thu. Feb. 8, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.35% (three month average) | RSI | 57 | Latest Price | $103.8834(-4.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(49%) IWD(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -1.175% in a week (0% probabilities). VIXM(-18%) TLT(-14%) UUP(-10%) IGOV(-4%) DIA(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.175% (StdDev 2.35%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
Resistance Level | $105.05 | 5 Day Moving Average | $106.87(-2.79%) | 10 Day Moving Average | $109.69(-5.29%) | 20 Day Moving Average | $105.05(-1.11%) | To recent high | -12% | To recent low | 16.7% | Market Cap | $183.28b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |